Together these findings suggest that GEN treatment can enhance radiosensitivity partially by promoting Bcl-xL and Beclin-1 dissociation to stimulate autophagy in NSCLC cells. The gene discussed is BCL2L1; the disease is non-small cell lung carcinoma.